- Presentations
- 2
- Markets
- 1
Sarclisa is a brand of Isatuximab marketed by Sanofi-Aventis, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Isatuximab
- Brand owner
- Sanofi-Aventis
- Registered in
- United States
- Strengths and forms
- 100 mg/5 mL injection, 500 mg/25 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Sarclisa 100 mg/5 mL injectionIntravenous Cold chain | Sanofi-Aventis | US FDA | Available on request |
| Sarclisa 500 mg/25 mL injectionIntravenous Cold chain | Sanofi-Aventis | US FDA | Available on request |
Equivalent brands
Other brands of Isatuximab.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Sarclisa
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.